SCLX FY 2023 Earnings — Scilex Holding Company Revenue & Financial Results | Market Cap Arena

SCLXScilex Holding Company

$73M

FY 2023 Earnings

Healthcare Drug Manufacturers - General

Income Statement

Revenue

$47M+22.9% YoY

Gross Profit

$31M66.5% margin

Operating Income

-$105M-225.6% margin

Net Income

-$114M-244.6% margin

EPS (Diluted)

$-44.85

Cash Flow

Operating Cash Flow

-$21M

Free Cash Flow

-$21M

Stock-Based Comp.

$15M

Balance Sheet

Total Assets

$101M

Total Liabilities

$274M

Stockholders' Equity

-$173M

Cash & Equivalents

$4M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$47M	$38M	+22.9%
Gross Profit	$31M	$27M	+14.0%
Operating Income	-$105M	-$51M	-108.2%
Net Income	-$114M	-$23M	-389.3%